CMR Surgical appoints Shlomi Cohen as Chief Financial Officer
May 07 2024 - 2:00AM
CMR Surgical appoints Shlomi Cohen as Chief Financial Officer
CMR Surgical appoints Shlomi
Cohen as Chief Financial Officer
-
Shlomi Cohen is a medical devices expert with significant
financial and operational experience.
CAMBRIDGE, UK – 7 May 2024, 07:00
(BST). CMR Surgical (CMR or ‘the Company’) – the
global surgical robotics business today announces the appointment
of Shlomi Cohen as Chief Financial Officer (CFO), effective
immediately.
Shlomi Cohen is a senior financial and
operations executive with extensive global leadership experience in
the MedTech sector. Most recently he was Chief Financial and
Operations Officer at Lumenis, a global company specialising in
innovative, minimally invasive medical devices and advanced
clinical solutions. At Lumenis, Shlomi was instrumental in driving
a significant increase in sales and profitability alongside
doubling the equity valuation of the business. Prior to his seven
years at Lumenis, Shlomi was Chief Financial Officer at Formula
Systems, a global software technology business. Shlomi is a
graduate of the General Management Program at Harvard Business
School, a graduate of the London Business School, and a Chartered
Accountant.
Shlomi will take up the role of CFO from Anna
Wasyl, who will be moving into an important new role in CMR’s
Commercial operations as Chief Commercial Partnerships and
Operations Officer, working closely with the Chief Commercial
Officer Massimiliano Colella.
Supratim Bose, Chief Executive Officer
of CMR Surgical, commented: “As we continue to invest in
bringing Versius to more customers around the world, I am pleased
to be further strengthening our leadership team with Shlomi’s
appointment. His deep knowledge of the medical devices industry,
and high growth businesses is a perfect fit for us. Shlomi will be
hugely valuable to the team as we continue our rapid global scale
up. I would like to thank Anna for her time as CFO and we look
forward to continuing to work closely with her in her new
role.”
Shlomi Cohen, Chief Financial Officer,
at CMR Surgical, said: "Versius is an extremely innovative
tool and I’m very excited to be part of the team that will help to
further accelerate CMR’s growth to help the Company to achieve its
mission of transforming surgery for good. CMR is an exciting,
highly regarded global business in the medical devices sector. The
Company is operating in a very fast-growing sector of the MedTech
market, so I look forward to helping the Company to maximise this
opportunity.”
The Company continues to scale up its operations
as it brings Versius to more markets around the world. Versius is a
small, modular, surgical robot that is being used by hospitals
around the world to perform complex surgical cases. Today, CMR
Surgical has over 160 Versius surgical robotic systems on the
market – with over 20,000 surgical procedures completed.
END
Media Contacts:
If you wish to see more, please contact CMR Surgical at:
Press Office, CMR SurgicalT
+44(0) 1223 755801E
pressoffice@cmrsurgical.com
Notes to editors:
The Versius Surgical Robotic System
Versius resets expectations of robotic surgery.
Versius fits into virtually any operating room set-up and
integrates seamlessly into existing workflows, increasing the
likelihood of robotic minimal access surgery (MAS). The small,
portable and modular design of Versius allows the surgeon to only
use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives
surgeons the choice of optimised port placement alongside the
dexterity and accuracy of small fully-wristed instruments. With 3D
HD vision, easy-to adopt instrument control and a choice of
ergonomic working positions, the open surgeon console has the
potential to reduce stress and fatigue and allows for clear
communication with the surgical team. By thinking laparoscopically
and operating robotically with Versius, patients, surgeons and
healthcare professionals can all benefit from the value that
robotic MAS brings.
But it’s more than just a robot. Versius
captures meaningful data with its wider digital ecosystem to
support a surgeon’s continuous learning. Through the Versius
Connect app, Versius Trainer and CMR clinical registry, Versius
unleashes a wealth of insights to ultimately improve surgical
care.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical devices
company dedicated to transforming surgery with Versius, a
next-generation surgical robot.
Headquartered in Cambridge, United Kingdom, CMR
is committed to working with surgeons, surgical teams and hospital
partners, to provide an optimal tool to make robotic minimal access
surgery universally accessible and affordable. With Versius, we are
on a mission to redefine the surgical robotics market with
practical, innovative technology and data that can improve surgical
care. Founded in 2014, CMR Surgical is a private limited company
backed by an international shareholder base.